Isoniazid is a first-line antibiotic used in the prevention and treatment of tuberculosis. It is currently the subject of various clinical trials for use in preventing TB in HIV-infected patients, who have a high risk of contracting the infection.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Molecule of the Week needs your suggestions!
If your favorite molecule is not in our archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.
